Tasha Armour founder and CEO of Rare Ovarian Cancer Incorporated – ROC Inc. talks to three leading international experts on Granulosa Cell Tumours GCT.

Dr Simon Chu research head of Hormone Cancer Therapeutic Laboratory at the Hudson Institute of Medical Research.

Professor Peter Fuller AM is physician-scientist who leads the Centre for Endocrinology and Metabolism at the Hudson Institute of Medical Research. Head of Endocrinology Unit, Monash Health

Professor Tom Jobling OAM, Director of Gynaecology Oncology at Monash Health

Granulosa Cell Tumour GCT has two subtypes adult aGCT and juvenile jGCT this is an opportunity to hear about what the latest developments for both of these subtypes and what is the future direction is for research and treatment for all GCT.

Sunday 1st March 8:00am AEDT

Register Now

Or visit the webinar landing page below

Granulosa Cell Tumour GCT, a rare ovarian cancer Q&A on Treatment, Challenges and Research Granulosa Cell Tumour GCT has two subtypes adult aGCT and juvenile jGCT this is an opportunity to hear about what the latest developments for both of these subtypes and what is the future direction is for research and treatment for all GCT.

Webinar is hosted on Bigmarker.com

Troubleshooting for attendees – BigMarker Follow New articles New articles and comments

If you have any issues or questions about the webinar email us at

events@rocinc.org.au